Figure 4. We used
3-(4,5-dimethylthiahiazol-2-y1)-2,5-diphenyltetrazolium bromide
and bromodeoxyuridine staining assays to determine that effects
of heparanase expression on human retinal vascular endothelial
cell proliferation. A:
3-(4,5-dimethylthiahiazol-2-y1)-2,5-diphenyltetrazolium bromide
(MTT) assays revealed that cell proliferation in the heparanase
small interfering RNA recombinant lentiviral vector
(HPSE-LV)-Glu30 group was significantly suppressed by HPSE-LV
compared with the Con-LV-Glu30 and Glu30 groups. Human retinal
vascular endothelial cell (HREC) proliferation in the Glu30
group was significantly higher than in the Glu5 and
HPSE-LV-Glu30 groups (●p<0.01 versus Glu5; ▲p<0.01 versus
HPSE-LV-Glu30). Each group experiment was repeated 3 times
(n=3). B, C: Bromodeoxyuridine (BrdU) staining
assays revealed that HPSE-LV-Glu30 cell growth was significantly
lower than in the Con-LV-Glu30 and Glu30 groups. The HREC growth
of the Glu30 group was significantly higher than in the Glu5 and
HPSE-LV-Glu30 groups. (●p<0.01 versus Glu5; ▲p<0.01 versus
HPSE-LV-Glu30). Data are presented as the mean±SD. Each group
experiment was repeated 3 times (n=3).
